Loading...
ONCO ONCONETIX INC US FDA Inspections 8-K Filing
Back
NCNT
NC
ONCONETIX INC
(ONCO)
Follow
FY2025 8 K
View More
Back
NCNT
NC
ONCONETIX INC
(ONCO)
Follow
FY2025 8 K
Filing:
8 K
Published on:
24 Mar '25
Delisting due to Non-Compli...
30 Apr '25
Delisting Risk
18 Apr '25
Business Combination
8 Apr '25
Management Changes
3 Apr '25
Clinical Data Release
24 Mar '25
Conference Announcement
19 Mar '25
Management Changes
28 Feb '25
Financial Agreement
18 Feb '25
Nasdaq Compliance Notice
24 Jan '25
Settlement Agreement
22 Jan '25
Nasdaq Notice
12 Dec '24
Asset Purchase Update
3 Dec '24
Auditor Resignation
21 Oct '24
Stock Split Update
9 Oct '24
PIPE Financing
3 Oct '24
Stock Split Action
24 Sep '24
Asset Purchase Agreement
20 Sep '24
Stock Split
20 Sep '24
Annual Meeting Results
10 Sep '24
Share Issuance Vote
4 Sep '24
Nasdaq Compliance Update
3 Sep '24
Shareholder Director Nomina...
7 Aug '24
Other Events
15 Jul '24
Definitive Agreement
11 Jul '24
Appointment of Interim CFO
14 Jun '24
Management Change
13 Jun '24
Delisting Notice
13 May '24
8-K Filing
26 Apr '24
Notice of Non-Compliance wi...
8 Apr '24
Amendment to Form 8-K
13 Mar '24
Amendment to Form 8-K/A
27 Feb '24
Appointment of Director
13 Feb '24
Appointment of Director
12 Feb '24
Investment Agreement
29 Jan '24
Departure of Directors or C...
19 Jan '24
Management Changes
12 Jan '24
Resignation
28 Dec '23
Share Exchange Agreement
27 Dec '23
Share Exchange Agreement
21 Dec '23
Press Release
19 Dec '23
Acquisition and Rebranding
18 Dec '23
Acquisition Announcement
1 Nov '23
Press Release
30 Oct '23
Termination of Agreement
18 Oct '23
CEO and CFO Appointments
10 Oct '23
Distribution Agreement and ...
3 Oct '23
Delisting
22 Sep '23
Resignation and Appointment
22 Aug '23
Agreement with Copay Consul...
10 Aug '23
Agreement for new preferred...
3 Aug '23
Agreement for PIO Exchange
1 Aug '23
Agreement with Knipper Health
31 Jul '23
Joint Ventures
25 Jul '23
Strategic Alliances
21 Jul '23
Press Release
17 Jul '23
Announcement
28 Jun '23
Announcement
21 Jun '23
Asset Purchase Agreement
14 Jun '23
Board Decisions and Annual ...
6 Jun '23
Presentation at JMP Securit...
15 May '23
Press Release
12 May '23
Conference Presentation
10 May '23
Press Release
25 Apr '23
Name Change
24 Apr '23
Asset Purchase Agreement
20 Apr '23
Announcement
12 Apr '23
Agreement for Stock Sale
29 Mar '23
Financial Results Press Rel...
13 Mar '23
Annual Meeting and Stockhol...
16 Feb '23
Resignation and Appointment
17 Jan '23
Presentation at Biotech Sho...
9 Jan '23
Presentation Filing
6 Jan '23
External Links:
SEC
AI Assistant
Close
ONCONETIX INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.